CDMO for peptide and oligonucleotide APIs across six GMP-certified facilities
PolyPeptide manufactures synthetic peptides and oligonucleotides as active pharmaceutical ingredients for biotech and pharma clients, operating six GMP-certified sites across Europe, the U.S., and India. The hiring mix is heavily weighted toward manufacturing and engineering roles, with active projects centered on equipment validation, SAP S/4HANA deployment, and lyophilization scale-up—signaling aggressive capacity expansion and digital modernization to handle a growing custom project pipeline.
Notable leadership hires: Shift Lead
PolyPeptide is a public CDMO specializing in peptide and oligonucleotide APIs for therapeutic and cosmetic applications. The company supports customers from preclinical through commercial manufacturing stages, serving pharmaceutical and biotech firms globally. Operations span six GMP-certified facilities and a global talent base. The core tech stack combines SAP enterprise resource planning with Veeva regulatory information management, LPLC/LC-MS analytical instruments, and Microsoft cloud infrastructure, reflecting the compliance and precision demands of pharmaceutical manufacturing.
PolyPeptide operates six GMP-certified facilities across Europe, the United States, and India. The company manufactures synthetic peptides, oligonucleotides, and generic peptides for pharmaceutical, biotech, and cosmetic clients.
PolyPeptide uses SAP S/4HANA for ERP and supply chain, Veeva RIM for regulatory information management, Dynamics 365 for CRM and supply chain, and Azure cloud infrastructure. The company is currently implementing a global SAP S/4HANA migration.
Other companies in the same industry, closest in size